510(k) Report

PMA · Approved

Approved

Presillion Plus Cocr Coronary Stent RX System

P110004PMAApproved Apr 12, 2012428-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medinol, Ltd. · MAF Stent, Coronary

Approved on Apr 12, 2012 through premarket approval, which rests on the device’s own clinical evidence after a 428-day review.

Decided
Apr 12, 2012
Review
428 days
Class
Class III
Product code
MAF
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P110004 has 32 supplements since 2013: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2013: 12014: 52015: 52016: 32017: 82018: 62019: 32020: 1
2013high 8 (2017) · low 1 (2013)2020
View FIG. 1 as a table
YearSupplements approved
20131
20145
20155
20163
20178
20186
20193
20201
FIG. 1 — Supplements to P110004, 2013–2020Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MAF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All MAF devices

MAF Stent, Coronary: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · MAF

2in 2025

2007: 342008: 412009: 362010: 552011: 672012: 772013: 412014: 532015: 222016: 262017: 352018: 322019: 252020: 212021: 132022: 82023: 82024: 32025: 22026 (partial year): 4
2007high 77 (2012) · low 2 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MAF

Too few MAF 510(k)s in any year since 2007 to give a median.

Recalls per year · MAF

1in 2019

2007: 12008: 12009: 52019: 1
2007high 5 (2009) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MAF

111in 2025

2007: 1,2012008: 1,2882009: 1,3702010: 1,5682011: 1,2332012: 1,0532013: 1,0492014: 8762015: 6642016: 6962017: 6952018: 6752019: 5612020: 4302021: 3292022: 2802023: 2072024: 2192025: 111
2007high 1,568 (2010) · low 111 (2025)2025

MAUDE reports naming product code MAF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200734—11,201
200841—11,288
200936—51,370
201055—01,568
201167—01,233
201277—01,053
201341—01,049
201453—0876
201522—0664
201626—0696
201735—0695
201832—0675
201925—1561
202021—0430
202113—0329
20228—0280
20238—0207
20243—0219
20252—0111
20264—0—
Cite this page

510(k) Report. “P110004: Presillion Plus Cocr Coronary Stent RX System.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P110004

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026